Tick-Borne Diseases: Clinical Trials

196 trials for Tick-Borne Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

92 completed, 37 recruiting, 32 unknown, 10 terminated. 39 Not applicable, 34 Phase 2, 25 Phase 3, 22 Phase 4, 15 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable39Completed 12, Recruiting 9, Unknown 9, Terminated 4, Not yet recruiting 3, Suspended 1, Withdrawn 1
Phase 234Completed 22, Recruiting 4, Withdrawn 3, Active not recruiting 2, Unknown 2, Terminated 1
Phase 325Completed 19, Recruiting 2, Terminated 2, Active not recruiting 1, Unknown 1
Phase 422Completed 17, Unknown 3, Not yet recruiting 1, Recruiting 1
Phase 115Completed 10, Recruiting 3, Not yet recruiting 1, Withdrawn 1
Early Phase 12Completed 1, Recruiting 1

Follow Tick-Borne Diseases: new trials by email Literature Review of Tick-Borne Diseases trials Research Report on Tick-Borne Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Doxycycline Boosted Therapy in Lyme Borreliosis: DoBo Study.
Hydroxychloroquin, Placebo, Doxycycline - Lyme Borreliosis, Nervous System
Phase 4Not yet recruitingRadboud University Medical Center502027-03-012026-08-27
The Precision Mito- Mito Map COMPASS Study
Mito Map Energy Score and Home Functional Assessments - Mitochondrial Diseases, Myalgic Encephalomyelitis Chronic Fatigue Syndrome
Not yet recruitingAI Agent Vault, Inc. d/b/a Precision Mito4002026-11-012026-10-02
Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related Disorders
Trisomy 8 Mosaicism, Trisomy 8 Associated Autoinflammatory Disease
RecruitingNational Institute of Allergy and Infectious Diseases (NIAID)7502026-10-282026-10-23
Flow Cytometric Immune Monitoring of B. Afzelii-Specific T Lymphocytes
Lyme Borreliosis, Lyme Disease
Not yet recruitingUniversity Hospital, Strasbourg, France202026-09-012026-07-14
UMIT-2 - Adaptive Phase IIb Platform Trial to Determine the Efficacy and Safety of Therapeutics for CCHF
Favipiravir, Ribavin, Optimised Standard of Care - Crimean-Congo Hemorrhagic Fever
Phase 2RecruitingLiverpool School of Tropical Medicine3782026-06-042026-08-07
Ceftriaxone for Post-Treatment Lyme Disease
Ceftriaxone treatment, Placebo - Post-Treatment Lyme Disease Syndrome
Phase 1 / Phase 2WithdrawnHackensack Meridian Health2026-05-142026-05-18
Development Of A Rapid Diagnostic Test To Identify Crimean-Congo Haemorrhagic Fever At The Point-Of-Care
Rapid Diagnostic Test - Crimean-Congo Haemorrhagic Fever
Not applicableRecruitingLiverpool School of Tropical Medicine4922026-05-042026-06-09
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1982 to Prevent Lyme Disease in Healthy Participants (18 to 70 Years of Age)
mRNA-1982, Placebo - Lyme Disease
Phase 2Active not recruitingModernaTX, Inc.3662026-04-292026-08-03
A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine
VLA15, Placebo - Lyme Disease
Phase 3RecruitingPfizer17122026-04-082026-05-06
A Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick Exposure
TP-05 (lotilaner) Low Dose, TP-05 (lotilaner) High Dose, Placebo - Lyme Disease
Phase 2Active not recruitingTarsus Pharmaceuticals, Inc.7222026-03-092026-07-09
Borrelia Arthritis - a Hidden Cause of Arthritis in Danish Patients?
Synovial fluid Borrelia burgdorferi PCR - Lyme Arthritis
Not yet recruitingFredrikke Christie Knudtzen3502026-01-012026-01-20
First-in-Human Study Testing a New Antibody Treatment for Tick-Borne Encephalitis in Healthy Volunteers.
Human monoclonal antibody TBE025, intravenous infusion - The Tick-borne Encephalitis Virus (TBEV)
Phase 1Not yet recruitingGiuseppe Pantaleo182026-01-012026-01-29
Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Dengue, Chikungunya
RecruitingInstitut Pasteur du Cambodge100002025-12-182026-01-22
A Study to Learn About Different Dosing Schedules of a Lyme Disease Vaccine in Healthy Adults
VLA15, Placebo - Lyme Borreliosis
Phase 3Active not recruitingPfizer2072025-11-192026-05-06
Human Babesiosis in Metropolitan France
Human Babesiosis
RecruitingUniversity Hospital, Strasbourg, France1002025-11-042026-01-16
Safety and Effectiveness of the BlinkER System in Participants With Facial Nerve Palsy
BlinkER device. - Bell's Palsy, Ramsay Hunt Syndrome
Not applicableNot yet recruitingNeurotrigger Ltd802025-10-012025-06-10
A Multicenter Real-life Study of Disseminated Borreliosis Cases Occurring in Patients Receiving Anti-CD20 Treatment in France
Borrelia Infections
RecruitingUniversity Hospital, Strasbourg, France1002025-08-292026-01-15
Effect of Saccharomyces Boulardii CNCM I-745 on Gut Microbiota in Patients Undergoing Antibiotic Therapy (in the Context of Erythema Migrans (Early Skin Form of Lyme Borreliosis))
Amoxicillin + Saccharomyces boulardii CNCM I-745, Amoxicillin + Placebo, Stool samples - Erythema Migrans of Lyme Disease
Phase 4RecruitingBiocodex1202025-07-162025-08-27
Transcranial Direct Current Stimulation for Post Treatment Lyme Disease
Transcranial Direct Current Stimulation (tDCS), Cognitive training - Post-Treatment Lyme Disease
Not applicableRecruitingColumbia University1102025-07-142026-05-06
Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic Fever
10 ug HDT 321, 25ug HDT-321, 50ug HDT-321 - Vaccine, Crimean-Congo Hemorrhagic Fever
Phase 1RecruitingHDT Bio482025-07-102025-07-28

Showing 20 of 196. Sign in to see all of them.

Narrower conditions

Lyme Disease (94)  ·  Encephalitis, Tick-Borne (50)  ·  Post-Lyme Disease Syndrome (22)  ·  Lyme Neuroborreliosis (19)  ·  Glossitis, Benign Migratory (15)  ·  Borrelia Infections (10)  ·  Tick Bites (7)  ·  Erythema Chronicum Migrans (6)  ·  Hemorrhagic Fever, Crimean (6)  ·  Tularemia (6)  ·  Fatigue Syndrome, Chronic (5)  ·  Relapsing Fever (5)  ·  Arthritis, Rheumatoid (4)  ·  Babesiosis (4)

Broader conditions

Infections (193)  ·  Vector Borne Diseases (193)  ·  Bacterial Infections and Mycoses (132)  ·  Gram-Negative Bacterial Infections (132)  ·  Bacterial Infections (131)  ·  Spirochaetales Infections (121)  ·  Borrelia Infections (110)  ·  Nervous System Diseases (79)  ·  Central Nervous System Diseases (74)  ·  Central Nervous System Infections (69)  ·  Virus Diseases (66)  ·  RNA Virus Infections (64)  ·  Arbovirus Infections (56)  ·  Brain Diseases (56)

Interventions

Doxycycline (20)  ·  Ceftriaxone (10)  ·  Vaccines (9)  ·  Blood Specimen Collection (6)  ·  FSME-IMMUN vaccine (3)  ·  Sodium Chloride (3)  ·  Surveys and Questionnaires (3)  ·  Amoxicillin (2)  ·  Anti-Bacterial Agents (2)  ·  Hydroxychloroquine (2)  ·  Meditation (2)  ·  lotilaner (2)  ·  Acetaminophen (1)  ·  Acyclovir (1)  ·  Arthrocentesis (1)

Sponsors

Pfizer (27)  ·  University Medical Centre Ljubljana (24)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (16)  ·  University Hospital, Strasbourg, France (14)  ·  U.S. Army Medical Research and Development Command (4)  ·  Medical University of Vienna (3)  ·  Novartis (3)  ·  Research Foundation for Mental Hygiene, Inc. (3)  ·  Brigham and Women's Hospital (2)  ·  Central Hospital, Nancy, France (2)  ·  Children's National Research Institute (2)  ·  Columbia University (2)  ·  Icahn School of Medicine at Mount Sinai (2)  ·  Johns Hopkins University (2)  ·  Liverpool School of Tropical Medicine (2)

Countries

United States (72)  ·  France (23)  ·  Slovenia (23)  ·  Germany (15)  ·  Austria (13)  ·  Poland (11)  ·  Sweden (7)  ·  Czechia (5)  ·  Switzerland (5)  ·  Belgium (4)  ·  Finland (4)  ·  Canada (3)  ·  China (3)  ·  Denmark (3)  ·  Netherlands (3)

Top investigators

Adriana R Marques, M.D. (8)  ·  Brian A Fallon, MD (4)  ·  Franc Strle, MD, PhD (4)  ·  Franc Strle, MD (3)  ·  Franc Strle, MD PhD (3)  ·  Ryszard Konior, MD (3)  ·  Dasa Stupica, MD, PhD (2)  ·  Fredrikke C Knudtzen, MD (2)  ·  Jerzy Brzostek, MD (2)  ·  Jerzy Dziduch, MD (2)

Results publications

PMID 30075748, PMID 21592984, PMID 28545923, PMID 38830375, PMID 39248571, PMID 16837678, PMID 18567539, PMID 22523260, PMID 24523212, PMID 25728316, PMID 27028911, PMID 27248436, PMID 27812090, PMID 28750854, PMID 28878005, PMID 29048514, PMID 29385444, PMID 29505880, PMID 30796143, PMID 30928173, PMID 31590634, PMID 31710647, PMID 32133487, PMID 32528467, PMID 32728481, PMID 34031759, PMID 34452033, PMID 35101266, PMID 35289310, PMID 35323885, PMID 35483736, PMID 35491421, PMID 35816681, PMID 36209759, PMID 36741404, PMID 37419129, PMID 38262807, PMID 38614954, PMID 39029481, PMID 40073309, PMID 40265182, PMID 40294611, PMID 41137175, PMID 41213278, PMID 41563326, PMID 41610944, PMID 41703273, PMID 41741501, PMID 42086599, PMID 42680745

NIH funding

2023 (3), 2009 (2), 2025 (2), 2008 (1), 2015 (1), P60AR036308 (1), R01AI031561 (1), R01OH010791 (1)